An Update on Treatment of Genotype 1 Chronic Hepatitis C

Barreto HJ, Lopes AD, Aguiar RC, Gondo FB, Neto, JG

BIP48 (Peginterferon Alfa 2b 48kDa) Compared With Pegasys

The study will be an open, multicenter, randomized, controlled phase II - III trial. Patients (n = 740) will be randomized (1:1) to receive BIP48 (peginterferon alfa-2b 48kDa) or Pegasys ® (peginte...

PWCA Competition Rules 2014

View presentation

Treatment

Increased frequency of micronuclei in the lymphocytes of

Recommendations for the Management of Hepatitis C Virus

EASL Recommendations on Treatment of Hepatitis C 2015

use as part of combination therapies for HCV infection. Sofosbuvir, a pangenotypic nucleotide analogue inhibitor of HCV RNA-dependent RNA polymerase, has been approved in January 2014. Simeprevir, ...

Porphyria Cutanea Tarda in Brazilian Patients: Association With

Summary on compassionate use for